HD news August: the latest in research and tech
This month, we received promising news on technological advances, findings from research teams, and the first in-human clinical…
-
-
Walk 4 Hope begins this month
Each year, Huntington’s Australia holds its Walk 4 Hope. The national community event takes place at locations across…
-
July’s HD news recap: what did we learn this month?
July was a busy month for Huntington’s disease research and news, with both disappointing announcements and encouraging research….
-
Update on the GENERATION HD2 and POINT-HD Clinical Studies from Roche
The Huntington’s disease community has received disappointing news about two clinical research studies. Roche announced last night that…
-
Have Your Say in 2026: Huntington’s Australia community survey
With the welcoming of the new financial year, Huntington’s Australia has sent out our 2026 Have Your Say…
-
Introducing the NDIS HD Planner Pathway
Huntington’s Australia welcomes the first dedicated NDIS HD Planner Pathway for people living with Huntington’s disease (HD). The NDIS HD Planner Pathway includes improvements to the access and planning process…
-
What’s been happening in Huntington’s disease research?
In this past quarter, we received a lot of news in the world of Huntington’s disease research. With encouraging trial results and…
-
HA Highlights: Winter edition is here
Winter is here, and it’s the perfect time to rug up, grab a cuppa, and read the latest…
-
Skyhawk Therapeutics: results from 12-month SKY-0515 treatment for Huntington’s disease
After twelve months, cUHDRS scores improved by +0.38 from baseline. In comparison, similar symptomatic patients would be expected…
